Morepen Laboratories Yönetim
Yönetim kriter kontrolleri 3/4
Morepen Laboratories CEO'su Sushil Suri, Oct2000 tarihinde atandı, in görev süresi 24.08 yıldır. şirketin hisselerinin 1.22% doğrudan sahiptir ve bu hisselerin değeri ₹ 496.16M dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 7.9 yıl ve 4.8 yıldır.
Anahtar bilgiler
Sushil Suri
İcra Kurulu Başkanı
₹39.1m
Toplam tazminat
| CEO maaş yüzdesi | n/a |
| CEO görev süresi | 24.1yrs |
| CEO sahipliği | 1.2% |
| Yönetim ortalama görev süresi | 7.9yrs |
| Yönetim Kurulu ortalama görev süresi | 4.8yrs |
Son yönetim güncellemeleri
Recent updates
There's Reason For Concern Over Morepen Laboratories Limited's (NSE:MOREPENLAB) Massive 30% Price Jump
Aug 20
Impressive Earnings May Not Tell The Whole Story For Morepen Laboratories (NSE:MOREPENLAB)
Aug 09Improved Earnings Required Before Morepen Laboratories Limited (NSE:MOREPENLAB) Stock's 29% Jump Looks Justified
Jul 05Does Morepen Laboratories (NSE:MOREPENLAB) Have A Healthy Balance Sheet?
Jun 13Morepen Laboratories Limited's (NSE:MOREPENLAB) Popularity With Investors Is Under Threat From Overpricing
Apr 23Morepen Laboratories (NSE:MOREPENLAB) Seems To Use Debt Quite Sensibly
Nov 23Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)
Sep 22Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?
Aug 10Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)
Sep 21Should You Be Adding Morepen Laboratories (NSE:MOREPENLAB) To Your Watchlist Today?
Apr 05Do Morepen Laboratories's (NSE:MOREPENLAB) Earnings Warrant Your Attention?
Sep 14Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?
May 21Does Morepen Laboratories (NSE:MOREPENLAB) Deserve A Spot On Your Watchlist?
Mar 12Our View On Morepen Laboratories' (NSE:MOREPENLAB) CEO Pay
Feb 22Is Morepen Laboratories Limited's (NSE:MOREPENLAB) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Feb 07Morepen Laboratories (NSE:MOREPENLAB) Shareholders Have Enjoyed A 91% Share Price Gain
Jan 21Morepen Laboratories (NSE:MOREPENLAB) Has A Pretty Healthy Balance Sheet
Jan 03
Is There More To The Story Than Morepen Laboratories's (NSE:MOREPENLAB) Earnings Growth?
Dec 16Should You Be Adding Morepen Laboratories (NSE:MOREPENLAB) To Your Watchlist Today?
Nov 28CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹1b |
| Jun 30 2024 | n/a | n/a | ₹1b |
| Mar 31 2024 | ₹39m | n/a | ₹962m |
| Dec 31 2023 | n/a | n/a | ₹761m |
| Sep 30 2023 | n/a | n/a | ₹531m |
| Jun 30 2023 | n/a | n/a | ₹477m |
| Mar 31 2023 | ₹48m | ₹44m | ₹387m |
| Dec 31 2022 | n/a | n/a | ₹428m |
| Sep 30 2022 | n/a | n/a | ₹553m |
| Jun 30 2022 | n/a | n/a | ₹768m |
| Mar 31 2022 | ₹91m | ₹87m | ₹1b |
| Dec 31 2021 | n/a | n/a | ₹1b |
| Sep 30 2021 | n/a | n/a | ₹1b |
| Jun 30 2021 | n/a | n/a | ₹1b |
| Mar 31 2021 | ₹54m | ₹51m | ₹971m |
| Dec 31 2020 | n/a | n/a | ₹814m |
| Sep 30 2020 | n/a | n/a | ₹684m |
| Jun 30 2020 | n/a | n/a | ₹453m |
| Mar 31 2020 | ₹17m | ₹16m | ₹336m |
| Dec 31 2019 | n/a | n/a | ₹331m |
| Sep 30 2019 | n/a | n/a | ₹312m |
| Jun 30 2019 | n/a | n/a | ₹340m |
| Mar 31 2019 | ₹12m | ₹11m | ₹288m |
| Dec 31 2018 | n/a | n/a | ₹252m |
| Sep 30 2018 | n/a | n/a | ₹267m |
| Jun 30 2018 | n/a | n/a | ₹308m |
| Mar 31 2018 | ₹6m | ₹4m | ₹296m |
Tazminat ve Piyasa: Sushil 'nin toplam tazminatı ($USD 464.10K ), Indian pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 271.25K ).
Tazminat ve Kazançlar: Sushil 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.
CEO
Sushil Suri (60 yo)
24.1yrs
Görev süresi
₹39,112,000
Tazminat
Mr. Sushil Suri, B.Sc., FCA has been Managing Director of Morepen Laboratories Limited since October 2000. He has been Chairman of Morepen Laboratories Limited since October 2000 and has been its Director...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Chairman & MD | 24.1yrs | ₹39.11m | 1.22% ₹ 496.2m | |
| Whole-Time Director | 9.8yrs | ₹21.80m | 1.01% ₹ 408.4m | |
| Chief Financial Officer | 10.3yrs | ₹9.80m | Veri yok | |
| General Manager of Process Engineering & Technology Transfer | no data | Veri yok | Veri yok | |
| Manager of Administration | no data | Veri yok | 0.58% ₹ 236.3m | |
| Company Secretary & Compliance Officer | 6yrs | ₹1.84m | Veri yok | |
| Functional Head of Talent Acquisition & HRBP | less than a year | Veri yok | Veri yok | |
| Chief Operating Officer of API | less than a year | Veri yok | Veri yok | |
| Head of Medipath Division | no data | Veri yok | 0.42% ₹ 168.9m | |
| Head of International Business Development | no data | Veri yok | Veri yok | |
| Chief Executive Officer of Consumer Division | no data | Veri yok | 0.56% ₹ 225.9m | |
| Chief of R&D | no data | Veri yok | Veri yok |
7.9yrs
Ortalama Görev Süresi
47.5yo
Ortalama Yaş
Deneyimli Yönetim: MOREPENLAB 'un yönetim ekibi deneyimli ve deneyimlidir ( 7.9 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Chairman & MD | 32.8yrs | ₹39.11m | 1.22% ₹ 496.2m | |
| Whole-Time Director | 5.3yrs | ₹21.80m | 1.01% ₹ 408.4m | |
| Independent Director | less than a year | Veri yok | Veri yok | |
| Independent Director | 5.3yrs | ₹520.00k | Veri yok | |
| Independent Director | 4.4yrs | ₹300.00k | Veri yok | |
| Independent Director | less than a year | Veri yok | Veri yok |
4.8yrs
Ortalama Görev Süresi
56yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: MOREPENLAB 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4.8 yıldır).